The Exeter Medical School has published new research in The Lancet Diabetes and Endocrinology. A study has revealed that a person’s characteristics such as age and weight are better indicators than the previously recognised model of dividing adults with diabetes into five subgroups.
Dr John Dennis said, “It’s recognised that not everyone with type 2 diabetes should be treated the same, yet there is currently no way to tell which tablet is likely to be the best for a particular person.
“It’s recognised that not everyone with type 2 diabetes should be treated the same, yet there is currently no way to tell which tablet is likely to be the best for a particular person.”
Our research shows that really simple clinical features such as age at diagnosis, sex, and kidney function provide a very effective and practical way to identify the best tablet for a particular person and to identify people at high risk of developing complications.”
The study had over 8,500 participants and is supported by the Medical Research Council. The full paper is entitled ‘Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared to models based on simple clinical features: an evaluation using clinical trial data’.
